InvestorsHub Logo
Followers 184
Posts 19312
Boards Moderated 0
Alias Born 03/07/2009

Re: buylow2 post# 321

Monday, 03/27/2017 10:01:53 AM

Monday, March 27, 2017 10:01:53 AM

Post# of 398
Yes, less termination costs and continuation of fovista trials ( if proceeded in Q3) would make it $5.50 cash at year end. But I expect a new direction via reverse merger before that, so fovista would not cut into cash position.